Analysts think PGEN stock price could increase by 303%
May 06, 2025, 11:25 AM
-11.51%
What does PGEN do
Precigen, a biotechnology company headquartered in Germantown, Maryland, focuses on synthetic biology technologies and develops therapies for urgent diseases. Founded in 2013, it operates through Biopharmaceuticals and Exemplar segments.
4 analysts think PGEN stock price will increase by 302.63%. The current median analyst target is $6.12 compared to a current stock price of $1.52. The lowest analysts target is $6.06 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
